MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis

Completed · Phase 3

Conditions studied: Post Menopausal Osteoporosis

In brief

This study will compare the efficacy and safety of different treatment regimens of oral Bonviva tablets in women with post-menopausal osteoporosis. Patients will also receive daily supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+ years, and the target sample size is 500+ individuals.

Key facts

Study ID

NCT00048061

Run by

Hoffmann-La Roche

People needed

1609

Starts

2002-04-01

Expected to finish

2004-12-01

Last updated by the study team

2018-03-29

Who can join

Age: 55 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• women 55-80 years of age;
• post-menopausal for >= 5 years;
• ambulatory.

You may not qualify if…

• malignant disease diagnosed within the previous 10 years (except basal cell cancer that has been successfully removed);
• breast cancer within the previous 20 years;
• allergy to bisphosphonates;
• previous treatment with an intravenous bisphosphonate at any time;
• previous treatment with an oral bisphosphonate within the last 6 months, >1 month of treatment within the last year, or >3 months of treatment within the last 2 years.

Where it is running

• Study site — Loma Linda, California, United States
• Study site — Los Angeles, California, United States
• Study site — Oakland, California, United States
• Study site — Rancho Mirage, California, United States
• Study site — Lakewood, Colorado, United States
• Study site — Gainesville, Florida, United States
• Study site — Bethesda, Maryland, United States
• Study site — Wheaton, Maryland, United States
• Study site — St Louis, Missouri, United States
• Study site — Billings, Montana, United States
• Study site — Omaha, Nebraska, United States
• Study site — Livingston, New Jersey, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — Portland, Oregon, United States
• Study site — Wyomissing, Pennsylvania, United States
• Study site — San Antonio, Texas, United States
• Study site — Richmond, Virginia, United States
• Study site — Seattle, Washington, United States
• Study site — Madison, Wisconsin, United States
• Study site — Adelaide, Australia
• Study site — Adelaide, Australia
• Study site — Parkville, Australia
• Study site — Perth, Australia
• Study site — Liège, Belgium
• Study site — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.